Increased expression of Ca2+-sensitive K+ channels in aorta of hypertensive rats

Hypertension

Volumn 30, Issue 6, 1997, Pages 1403-1409

  Liu, Yanping ^a   Pleyte, Kay ^a   Knaus, Hans Guenther ^b   Rusch, Nancy J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Institute for Biochemical Pharmacology   (Austria)

Author keywords

Iberiotoxin; Ion channel expression; K+ channel; Vascular smooth muscle

Indexed keywords

CALCIUM ION; IBERIOTOXIN; POTASSIUM CHANNEL; CALCIUM; MESSENGER RNA; PEPTIDE; SCORPION VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; BIOSYNTHESIS; CELL MEMBRANE POTENTIAL; DRUG EFFECT; GENETIC TRANSCRIPTION; METABOLISM; PATCH CLAMP; PATHOPHYSIOLOGY; PHYSIOLOGY; REFERENCE VALUE; SPRAGUE DAWLEY RAT; WISTAR KYOTO RAT;

ANIMALS; AORTA; CALCIUM; HYPERTENSION; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; PATCH-CLAMP TECHNIQUES; PEPTIDES; POTASSIUM CHANNELS; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; RNA, MESSENGER; SCORPION VENOMS; TRANSCRIPTION, GENETIC;

EID: 0030608804     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.6.1403     Document Type: Article

References (30)

1. + current is enhanced in arterial membranes of hypertensive rats. Hypertension. 1992;19:301-307.
2. Rusch NJ, Runnells AM. Remission of high blood pressure reverses arterial potassium channel alterations. Hypertension. 1994; 23:941-945.
3. + current in arterial membranes from genetically hypertensive rats. Am J Physiol. 1993;264:H1337-H1345.
4. Liu Y, Jones AW, Sturek M. Increased barium influx and potassium current in stroke-prone spontaneously hypertensive rats. Hypertension. 1994;23:1091-1095.
5. + current in arterial smooth muscle cells from aldosterone-salt hypertensive rats. Am J Physiol. 1995;269:H1246-H1257.
6. + channels in genetic and nongenetic hypertension. Circ Res. 1996;79:295-301.
7. + channels in resting state of carotid arteries from SHR. Am J Physiol. 1993;265:H843-H851.
8. + channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats. Br J Pharmacol. 1993;108:214-223.
9. Kolias TJ, Chai S, Webb RC. Potassium channel antagonists and vascular reactivity in stroke-prone spontaneously hypertensive rats. Am J Hypertens. 1993;26:528-533.
10. + channels in hypertension. Clin Exp Pharmacol Physiol. 1996;23:1077-1082.
11. Wang DH, Du Y, Yao A. Regulation of the gene-encoding angiotensin II receptor in vascular tissue. Microcirculation. 1996;3: 237-239.
12. Li P, Zou AP, al-Kayed NJ, Rusch NJ, Harder DR. Guanine nucleotide-binding proteins in aortic smooth muscle from hypertensive rats. Hypertension. 1994;23:914-918.
13. Kanagy NL, Webb RC. Increased responsiveness and decreased expression of G proteins in deoxycorticosterone hypertension. Hypertension. 1996;27:740-745.
14. Papp B, Corvazier E, Magnier C, Kovacs T, Bourdeau N, Levy-Toledano S, Bredoux R, Levy B, Poitevin P, Lompre AM, Wuytack F, Enouf J. Spontaneously hypertensive rats and platelet Ca(2+)-ATPases: specific up-regulation of the 97-kDa isoform. Biochem J. 1993;295:685-690.
15. Sickowski M, Davies JE, Ng LL. Sodium-hydrogen antiporter protein in normotensive Wistar-Kyoto rats and spontaneously hypertensive rats. J Hypertens. 1994;12:775-781.
16. Resnick N, Gimbrone MA. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 1995;9:874-882.
17. McCobb DP, Fowler NL, Featherstone T, Lingle CJ, Saito M, Krause JE, Salkoff L. A human calcium-activated potassium channel gene expressed in vascular smooth muscle. Am J Physiol. 1995;269:H767-H777.
18. + channel. J Biol Chem. 1995;270:22434-22439.
19. Jackson WF, Huebner JM, Rusch NJ. Enzymatic isolation and characterization of single vascular smooth muscle cells from cremasteric arterioles. Microcirculation. 1996;3:313-328.
20. Knaus H-G, Eberhart A, Glossmann H, Munujos P, Kaczorowski GJ, Garcia ML. Pharmacology and structure of high conductance calcium-activated potassium channels. Cell Signal. 1994;6:861-870.
21. Mattson DL, Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension. 1996;27:688-692.
22. Bohlender J, Fukamizu A, Lippoldt A, Nomura T, Dietz R, Menard J, Murakami K, Luft FC, Detlev G. High human renin hypertension in transgenic rats. Hypertension. 1997;29:428-434.
23. Jones AW. Arterial tissue cations. In: Genest J, Kuchel O, Hamet P, Cantin M, eds. Hypertension, Physiology and Treatment. New York, NY: McGraw-Hill; 1993:488-497.
24. Adelman JP, Shen KZ, Kavanaugh MP, Warren RA, Wu Y, Lagrutta A, Bond CT, North RA. Calcium-activated potassium channels expressed from cloned complementary DNAs. Neuron. 1992;9:209-216.
25. Lagrutta A, Shen KZ, North RA, Adelman JP. Functional differences among alternatively spliced variants of Slowpoke, a Drosophila calcium-activated potassium channel. J Biol Chem. 1994; 269:20347-20351.
26. Ca channels determined by a separable domain. Neuron. 1994;13: 671-681.
27. McManus OB, Helms LMH, Pallanck L, Ganetzky B, Swanson R, Leonard RJ. Functional role of the β subunit of high conductance calcium-activated potassium channels. Neuron. 1995;14:645-650.
28. + channels and membrane fluidity in vascular smooth muscle cells. Pflugers Arch. 1989;415:262-268.
29. Bradbury NA, Bridges RJ. Role of membrane trafficking in plasma membrane solute transport. Am J Physiol. 1994;267:C1-C24.
30. Smith AE. Treatment of cystic fibrosis based on understanding CFTR. J Inher Metab Dis. 1995;18:508-516.